SavedAdd your journal

Journals / KONURALP TIP DERGİSİ / 2021 / Cilt: 13 - Sayı: 3

Evaluation of tetanus immunoglobulin G levels according to age and sociodemographic characteristics: A community-based study

Tetanoz immünoglobulin G düzeylerinin yaş ve sosyodemografik özelliklere göre değerlendirilmesi: Toplum temelli bir çalışma

Metin Doğan
Ruhuşen Kutlu
Mahmut Baykan
Ali Rıza ÇAPA
Pages
488–496
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Of the participants, 756 (82.5%) had protective tetanus antibody levels (≥0.1 IU/mL), and 160 (17.5%) had unreliable protective antibody levels (

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In the present study, it was aimed to determine the serum tetanus antibody levels in individuals aged 18 and over and examine whether the antibody levels have changed with advancing age.
📊
Key Findings & Data:Methods: This descriptive research was carried out on 916 adults aged 18 years and over in Konya.
💡
Conclusion & Impact:Of the participants, 756 (82.5%) had protective tetanus antibody levels (≥0.1 IU/mL), and 160 (17.5%) had unreliable protective antibody levels (
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Tetanoz antikoru · aşı · yetişkin

Abstract

Objective: In the present study, it was aimed to determine the serum tetanus antibody levels in individuals aged 18 and over and examine whether the antibody levels have changed with advancing age. Methods: This descriptive research was carried out on 916 adults aged 18 years and over in Konya. A survey containing sociodemographic features was filled and tetanus IgG levels was measured. Results: In this study, 916 suitable people in total who consisted of 68.4% (n=627) female and 31.6% (n=289) male were included. Of the participants, 756 (82.5%) had protective tetanus antibody levels (≥0.1 IU/mL), and 160 (17.5%) had unreliable protective antibody levels (

Özet

Amaç: Sunulan çalışmada serum tetanoz antikor seviyelerinin 18 yaş ve üzeri bireylerde belirlenmesi ve ilerleyen yaş ile birlikte antikor düzeylerinin değişip değişmediğinin incelemesi amaçlanmıştır. Gereç ve Yöntem: Bu tanımlayıcı araştırma Konya'da 18 yaş ve üstü 916 yetişkin üzerinde yapılmıştır. Sosyodemografik özellikler içeren bir anket dolduruldu ve tetanoz IgG düzeyleri ölçüldü. Bulgular: Çalışmaya % 68,4 (n = 627) kadın, % 31,6 (n = 289) erkek toplam 916 uygun kişi alındı. Katılımcıların 756'sında (%82,5) koruyucu tetanoz antikor düzeyi (≥0,1 IU / mL) ve 160'ında (%17,5) güvenilir olmayan koruyucu antikor düzeyi (

🔖

Cite This Article

Doğan, M., Kutlu, R., Baykan, M., ÇAPA, A. R. (2022). Evaluation of tetanus immunoglobulin G levels according to age and sociodemographic characteristics: A community-based study. KONURALP TIP DERGİSİ, Cilt: 13 - Sayı: 3, 488–496. https://ajindex.com/articles/575505

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. REFERENCES 1. Bleck TP. Clostridium tetani (tetanus). In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone
  2. p. 3091-6. 2. Weinberger B. Vaccines for the elderly: current use and future challenges.Immun Ageing. 2018
  3. doi: 10.1186/s12979-017-0107-2. 3. Gergen PJ, McQuillan GM, Kiely M, Ezzati-Rice TM, Sutter RW, Virella G. A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med. 1995
  4. 332(12):761-6. 4. Türkiye EKMUD-Erişkin Bağışıklama Rehberi. https://www.ekmud.org.tr/haber/264-turkiye-ekmud-eriskin-bagisiklama-rehberi Access date: 12.02.2020. 5. McQuillan GM, Kruszon-Moran D, Deforest A, Chu SY, Wharton M. Serologic immunity to diphtheria and tetanus in the United States. Ann Intern Med. 2002
  5. 136(9):660-6. 6. Ergönül O, Sozen T, Tekeli E. Immunity to Tetanus Among Adults in Turkey. Scand J Infect Dis. 2001
  6. 33(10):728-30. doi: 10.1080/003655401317074491. 7. Tetanus toxin IgG ELISA - DRG Diagnostics. www.drg-diagnostics.de/./eia-3514_ifu--tetanus-toxin-IgG. 8. MacLennan R, Schofield FD, Pittman M, Hardegree MC, Barile MF (1965). Immunization against neonatal tetanus in New Guinea: antitoxin response of pregnant women to adjuvant and plain toxoids. Bull World Health Organ.32:683–97. 9. Quinn HE, McIntyre PB. Tetanus in the elderly--An important preventable disease in Australia. Vaccine. 2007
  7. 25(7):1304-9. 10. Wu CJ, Ko HC, Lee HC, Tsai WC, Li MG, Pao YZ, Lee NY, Chang CM, Shih HI, Ko WC. Decline of tetanus antitoxin level with age in Taiwan. J Formos Med Assoc. 2009
  8. 108(5):395-401. 11. Saxena S, Jais M, Dutta R, Dutta AK. Serological immunity to diphtheria and tetanus in healthy adults in Delhi, India. Trop Doct. 2009
  9. 39(3):160-3. 12. Domínguez A, Plans P, Costa J, Espuñes J, Cardeñosa N, Salleras L, Plasència A. The seroepidemiology of tetanus in Catalonia, Spain. Med Microbiol Immunol. 2007
  10. 196(2):115-9. Epub 2007 Jan 23 13. Tansel O, Ekuklu G, Eker A, Kunduracilar H, Yuluğkural Z, Yüksel P. Community-based seroepidemiology of diphtheria and tetanus in Edirne, Turkey. Jpn J Infect Dis. 2009
  11. 62(4):275-8. 14. Aue A, Hennig H, Krüger S, Closius B, Kirchner H, Seyfarth M. Immunity against diphtheria and tetanus in German blood donors. Med Microbiol Immunol 2003
  12. 192(2):93-7. 15. Symeonidis N, Symeonidis C, Souliou E, Houiazi E, Diza E, Symeonidis A, Antoniadis A. Serological survey of immunity to tetanus in